Direct-to-patient laboratory test reporting: Balancing access with effective clinical communication

JAMA

Volumn 312, Issue 2, 2014, Pages 127-128

  Young, Michael J ^a,b   Scheinberg, Ethan ^b   Bursztajn, Harold ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD LAW SCHOOL   (United States)

^c The American Unit of the UNESCO Bioethics Chair   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; COMMUNICATION SKILL; CONFUSION (UNCERTAINTY); COST BENEFIT ANALYSIS; HEALTH CARE ACCESS; HEALTH CARE ORGANIZATION; HEALTH CARE PRACTICE; HEALTH CARE SYSTEM; HIV TEST; HUMAN; INFORMATION PROCESSING; INTERNET; LABORATORY TEST; MEDICAL INFORMATION; NOTE; OUTCOME ASSESSMENT; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; SAFETY; TOTAL QUALITY MANAGEMENT; TREATMENT REFUSAL;

ACCESS TO INFORMATION; COMMUNICATION; DIAGNOSTIC TESTS, ROUTINE; DISCLOSURE; HUMANS; MEDICAL RECORDS; PHYSICIAN-PATIENT RELATIONS; UNITED STATES; UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES;

EID: 84903881373     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.5823     Document Type: Note

References (5)

1. Centers for Medicare & Medicaid Services (CMS), HHS; Centers for Disease Control and Prevention (CDC), HHS; Office for Civil Rights (OCR), HHS. CLIA program and HIPAA privacy rule: patients' access to test reports. Fed Regist. 2014;79(25):7289-7316.
2. De Freitas J, Falls BA, Haque OS, Bursztajn HJ. Vulnerabilities to misinformation in online pharmaceutical marketing. J R Soc Med. 2013;106(5):184-189.
3. Standard: test report. 42 CFR 493.1291 (2007).
4. Bursztajn H, Feinbloom R, Hamm R, Brodsky A. Medical Choices, Medical Chances: How Patients, Families, and Physicians Can Cope With Uncertainty. New York, NY: Routledge; 1990.
5. Djulbegovic B, Paul A. From efficacy to effectiveness in the face of uncertainty: indication creep and prevention creep. JAMA. 2011;305(19):2005- 2006.